Emma M Perkins1,2,3, Karen Burr1,2,4, Poulomi Banerjee2,4, Arpan R Mehta1,2,4, Owen Dando3,4,5, Bhuvaneish T Selvaraj1,2,4, Daumante Suminaite3, Jyoti Nanda1,2,4, Christopher M Henstridge1,6, Thomas H Gillingwater1,3, Giles E Hardingham3,4,5, David J A Wyllie3,5,7, Siddharthan Chandran8,9,10,11,12, Matthew R Livesey13,14,15,16. 1. Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK. 2. Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK. 3. Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK. 4. UK Dementia Research Institute at the University of Edinburgh, Edinburgh, EH16 4SB, UK. 5. Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, UK. 6. Division of Systems Medicine, School of Medicine, University of Dundee, Dundee, DD1 9SY, UK. 7. Centre for Brain Development and Repair, inStem, Bangalore, 560065, India. 8. Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK. siddharthan.chandran@ed.ac.uk. 9. Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK. siddharthan.chandran@ed.ac.uk. 10. UK Dementia Research Institute at the University of Edinburgh, Edinburgh, EH16 4SB, UK. siddharthan.chandran@ed.ac.uk. 11. Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, UK. siddharthan.chandran@ed.ac.uk. 12. Centre for Brain Development and Repair, inStem, Bangalore, 560065, India. siddharthan.chandran@ed.ac.uk. 13. Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK. M.R.Livesey@Sheffield.ac.uk. 14. Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK. M.R.Livesey@Sheffield.ac.uk. 15. Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, UK. M.R.Livesey@Sheffield.ac.uk. 16. Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2HQ, UK. M.R.Livesey@Sheffield.ac.uk.
Abstract
BACKGROUND: Physiological disturbances in cortical network excitability and plasticity are established and widespread in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients, including those harbouring the C9ORF72 repeat expansion (C9ORF72RE) mutation - the most common genetic impairment causal to ALS and FTD. Noting that perturbations in cortical function are evidenced pre-symptomatically, and that the cortex is associated with widespread pathology, cortical dysfunction is thought to be an early driver of neurodegenerative disease progression. However, our understanding of how altered network function manifests at the cellular and molecular level is not clear. METHODS: To address this we have generated cortical neurons from patient-derived iPSCs harbouring C9ORF72RE mutations, as well as from their isogenic expansion-corrected controls. We have established a model of network activity in these neurons using multi-electrode array electrophysiology. We have then mechanistically examined the physiological processes underpinning network dysfunction using a combination of patch-clamp electrophysiology, immunocytochemistry, pharmacology and transcriptomic profiling. RESULTS: We find that C9ORF72RE causes elevated network burst activity, associated with enhanced synaptic input, yet lower burst duration, attributable to impaired pre-synaptic vesicle dynamics. We also show that the C9ORF72RE is associated with impaired synaptic plasticity. Moreover, RNA-seq analysis revealed dysregulated molecular pathways impacting on synaptic function. All molecular, cellular and network deficits are rescued by CRISPR/Cas9 correction of C9ORF72RE. Our study provides a mechanistic view of the early dysregulated processes that underpin cortical network dysfunction in ALS-FTD. CONCLUSION: These findings suggest synaptic pathophysiology is widespread in ALS-FTD and has an early and fundamental role in driving altered network function that is thought to contribute to neurodegenerative processes in these patients. The overall importance is the identification of previously unidentified defects in pre and postsynaptic compartments affecting synaptic plasticity, synaptic vesicle stores, and network propagation, which directly impact upon cortical function.
BACKGROUND: Physiological disturbances in cortical network excitability and plasticity are established and widespread in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients, including those harbouring the C9ORF72 repeat expansion (C9ORF72RE) mutation - the most common genetic impairment causal to ALS and FTD. Noting that perturbations in cortical function are evidenced pre-symptomatically, and that the cortex is associated with widespread pathology, cortical dysfunction is thought to be an early driver of neurodegenerative disease progression. However, our understanding of how altered network function manifests at the cellular and molecular level is not clear. METHODS: To address this we have generated cortical neurons from patient-derived iPSCs harbouring C9ORF72RE mutations, as well as from their isogenic expansion-corrected controls. We have established a model of network activity in these neurons using multi-electrode array electrophysiology. We have then mechanistically examined the physiological processes underpinning network dysfunction using a combination of patch-clamp electrophysiology, immunocytochemistry, pharmacology and transcriptomic profiling. RESULTS: We find that C9ORF72RE causes elevated network burst activity, associated with enhanced synaptic input, yet lower burst duration, attributable to impaired pre-synaptic vesicle dynamics. We also show that the C9ORF72RE is associated with impaired synaptic plasticity. Moreover, RNA-seq analysis revealed dysregulated molecular pathways impacting on synaptic function. All molecular, cellular and network deficits are rescued by CRISPR/Cas9 correction of C9ORF72RE. Our study provides a mechanistic view of the early dysregulated processes that underpin cortical network dysfunction in ALS-FTD. CONCLUSION: These findings suggest synaptic pathophysiology is widespread in ALS-FTD and has an early and fundamental role in driving altered network function that is thought to contribute to neurodegenerative processes in these patients. The overall importance is the identification of previously unidentified defects in pre and postsynaptic compartments affecting synaptic plasticity, synaptic vesicle stores, and network propagation, which directly impact upon cortical function.
Authors: Yoshitsugu Aoki; Raquel Manzano; Yi Lee; Ruxandra Dafinca; Misako Aoki; Andrew G L Douglas; Miguel A Varela; Chaitra Sathyaprakash; Jakub Scaber; Paola Barbagallo; Pieter Vader; Imre Mäger; Kariem Ezzat; Martin R Turner; Naoki Ito; Samanta Gasco; Norihiko Ohbayashi; Samir El Andaloussi; Shin'ichi Takeda; Mitsunori Fukuda; Kevin Talbot; Matthew J A Wood Journal: Brain Date: 2017-04-01 Impact factor: 13.501
Authors: Bahman Nasseroleslami; Stefan Dukic; Michael Broderick; Kieran Mohr; Christina Schuster; Brighid Gavin; Russell McLaughlin; Mark Heverin; Alice Vajda; Parameswaran M Iyer; Niall Pender; Peter Bede; Edmund C Lalor; Orla Hardiman Journal: Cereb Cortex Date: 2019-01-01 Impact factor: 5.357
Authors: Ramesh K Narayanan; Marie Mangelsdorf; Ajay Panwar; Tim J Butler; Peter G Noakes; Robyn H Wallace Journal: Amyotroph Lateral Scler Frontotemporal Degener Date: 2012-10-24 Impact factor: 4.092
Authors: Brigid K Jensen; Martin H Schuldi; Kevin McAvoy; Katelyn A Russell; Ashley Boehringer; Bridget M Curran; Karthik Krishnamurthy; Xinmei Wen; Thomas Westergard; Le Ma; Aaron R Haeusler; Dieter Edbauer; Piera Pasinelli; Davide Trotti Journal: EMBO Mol Med Date: 2020-04-29 Impact factor: 12.137
Authors: Daniel Sommer; Sandeep Rajkumar; Mira Seidel; Amr Aly; Albert Ludolph; Ritchie Ho; Tobias M Boeckers; Alberto Catanese Journal: Front Mol Neurosci Date: 2022-06-14 Impact factor: 6.261
Authors: Sai Zhang; Johnathan Cooper-Knock; Annika K Weimer; Minyi Shi; Tobias Moll; Jack N G Marshall; Calum Harvey; Helia Ghahremani Nezhad; John Franklin; Cleide Dos Santos Souza; Ke Ning; Cheng Wang; Jingjing Li; Allison A Dilliott; Sali Farhan; Eran Elhaik; Iris Pasniceanu; Matthew R Livesey; Chen Eitan; Eran Hornstein; Kevin P Kenna; Jan H Veldink; Laura Ferraiuolo; Pamela J Shaw; Michael P Snyder Journal: Neuron Date: 2022-01-18 Impact factor: 18.688
Authors: Iris-Stefania Pasniceanu; Manpreet Singh Atwal; Cleide Dos Santos Souza; Laura Ferraiuolo; Matthew R Livesey Journal: Front Cell Neurosci Date: 2021-12-15 Impact factor: 5.505
Authors: Matthew J Broadhead; Calum Bonthron; Julia Waddington; William V Smith; Maite F Lopez; Sarah Burley; Jessica Valli; Fei Zhu; Noboru H Komiyama; Colin Smith; Seth G N Grant; Gareth B Miles Journal: Acta Neuropathol Date: 2022-03-19 Impact factor: 15.887
Authors: Lara Marrone; Paolo M Marchi; Christopher P Webster; Raffaele Marroccella; Ian Coldicott; Steven Reynolds; João Alves-Cruzeiro; Zih-Liang Yang; Adrian Higginbottom; Mukhran Khundadze; Pamela J Shaw; Christian A Hübner; Matthew R Livesey; Mimoun Azzouz Journal: Hum Mol Genet Date: 2022-08-23 Impact factor: 5.121
Authors: Claudia S Bauer; Rebecca N Cohen; Francesca Sironi; Matthew R Livesey; Thomas H Gillingwater; J Robin Highley; Daniel J Fillingham; Ian Coldicott; Emma F Smith; Yolanda B Gibson; Christopher P Webster; Andrew J Grierson; Caterina Bendotti; Kurt J De Vos Journal: Acta Neuropathol Date: 2022-07-25 Impact factor: 15.887